Logo image of ONCY

ONCOLYTICS BIOTECH INC (ONCY) Stock Overview

NASDAQ:ONCY - CA6823108759 - Common Stock

1.11 USD
-0.05 (-4.31%)
Last: 9/4/2025, 11:56:58 AM

ONCY Key Statistics, Chart & Performance

Key Statistics
52 Week High1.53
52 Week Low0.33
Market Cap98.59M
Shares88.82M
Float85.33M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.27
PEN/A
Fwd PEN/A
Earnings (Next)11-10 2025-11-10/amc
IPO06-01 2000-06-01
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


ONCY short term performance overview.The bars show the price performance of ONCY in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 50 100 150 200

ONCY long term performance overview.The bars show the price performance of ONCY in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 -40

The current stock price of ONCY is 1.11 USD. In the past month the price increased by 22.11%. In the past year, price increased by 21.09%.

ONCOLYTICS BIOTECH INC / ONCY Daily stock chart

ONCY Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 20.1 376.10B
AMGN AMGEN INC 12.89 151.36B
GILD GILEAD SCIENCES INC 14.56 139.79B
VRTX VERTEX PHARMACEUTICALS INC 23.38 101.53B
REGN REGENERON PHARMACEUTICALS 12.44 60.20B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 59.58B
ARGX ARGENX SE - ADR 78.94 44.78B
ONC BEONE MEDICINES LTD-ADR 6.46 38.06B
INSM INSMED INC N/A 29.93B
BNTX BIONTECH SE-ADR N/A 24.45B
NTRA NATERA INC N/A 22.91B
BIIB BIOGEN INC 8.64 20.27B

About ONCY

Company Profile

ONCY logo image Oncolytics Biotech, Inc. engages in the provision of development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. The company is headquartered in Calgary, Alberta. The company went IPO on 2000-06-01. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The company acts by inducing anti-cancer immune responses and promotes an inflamed tumor phenotype, turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. The firm is also advancing its programs in hormone receptor-positive / human epidermal growth factor 2-negative (HR+/ HER2-) advanced and metastatic breast cancer (mBC) and metastatic pancreatic ductal adenocarcinoma (PDAC) to registration-enabled clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

Company Info

ONCOLYTICS BIOTECH INC

804, 322 - 11 Avenue Sw, Calgary Alberta Canada T2n 1X7

Calgary ALBERTA T2N 1X7 CA

CEO: Matthew C. Coffey

Employees: 29

ONCY Company Website

ONCY Investor Relations

Phone: 14036707377

ONCOLYTICS BIOTECH INC / ONCY FAQ

What is the stock price of ONCOLYTICS BIOTECH INC today?

The current stock price of ONCY is 1.11 USD. The price decreased by -4.31% in the last trading session.


What is the ticker symbol for ONCOLYTICS BIOTECH INC stock?

The exchange symbol of ONCOLYTICS BIOTECH INC is ONCY and it is listed on the Nasdaq exchange.


On which exchange is ONCY stock listed?

ONCY stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for ONCOLYTICS BIOTECH INC stock?

8 analysts have analysed ONCY and the average price target is 3.32 USD. This implies a price increase of 199.04% is expected in the next year compared to the current price of 1.11. Check the ONCOLYTICS BIOTECH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ONCOLYTICS BIOTECH INC worth?

ONCOLYTICS BIOTECH INC (ONCY) has a market capitalization of 98.59M USD. This makes ONCY a Micro Cap stock.


How many employees does ONCOLYTICS BIOTECH INC have?

ONCOLYTICS BIOTECH INC (ONCY) currently has 29 employees.


What are the support and resistance levels for ONCOLYTICS BIOTECH INC (ONCY) stock?

ONCOLYTICS BIOTECH INC (ONCY) has a support level at 1.07 and a resistance level at 1.26. Check the full technical report for a detailed analysis of ONCY support and resistance levels.


Should I buy ONCOLYTICS BIOTECH INC (ONCY) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ONCOLYTICS BIOTECH INC (ONCY) stock pay dividends?

ONCY does not pay a dividend.


When does ONCOLYTICS BIOTECH INC (ONCY) report earnings?

ONCOLYTICS BIOTECH INC (ONCY) will report earnings on 2025-11-10, after the market close.


What is the Price/Earnings (PE) ratio of ONCOLYTICS BIOTECH INC (ONCY)?

ONCOLYTICS BIOTECH INC (ONCY) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.27).


What is the Short Interest ratio of ONCOLYTICS BIOTECH INC (ONCY) stock?

The outstanding short interest for ONCOLYTICS BIOTECH INC (ONCY) is 2.91% of its float. Check the ownership tab for more information on the ONCY short interest.


ONCY Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to ONCY. When comparing the yearly performance of all stocks, ONCY is one of the better performing stocks in the market, outperforming 97.35% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ONCY Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to ONCY. ONCY may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ONCY Financial Highlights

Over the last trailing twelve months ONCY reported a non-GAAP Earnings per Share(EPS) of -0.27. The EPS increased by 2.63% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -152.26%
ROE -499.46%
Debt/Equity 0.1
Chartmill High Growth Momentum
EPS Q2Q%30%
Sales Q2Q%N/A
EPS 1Y (TTM)2.63%
Revenue 1Y (TTM)N/A

ONCY Forecast & Estimates

8 analysts have analysed ONCY and the average price target is 3.32 USD. This implies a price increase of 199.04% is expected in the next year compared to the current price of 1.11.


Analysts
Analysts77.5
Price Target3.32 (199.1%)
EPS Next Y21.99%
Revenue Next YearN/A

ONCY Ownership

Ownership
Inst Owners1.52%
Ins Owners4.01%
Short Float %2.91%
Short Ratio2.33